Yulin Huang
State Key Laboratory Of Oncology In South China
Guangzhou, China
Guangzhou, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 17 publications
Correction: ZNF655 promotes tumor growth and chemoresistance by targeting MAFF-CCND1 axis in ovarian cancer.
Journal: Cancer cell international
Published: June 28, 2026
NMB+CXCL13+CD4+ T Cell-Derived Neuromedin B Promotes Neuropeptide S Receptor 1-Positive Malignant Cell Senescence and Malignancy.
Journal: Cancer immunology research
Published: September 02, 2025
ZNF655 promotes tumor growth and chemoresistance by targeting MAFF-CCND1 axis in ovarian cancer.
Journal: Cancer cell international
Published: March 02, 2025
CDC7 Inhibition Potentiates Antitumor Efficacy of PARP Inhibitor in Advanced Ovarian Cancer.
Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)
Published: April 10, 2024
Pharmacological modulation of RB1 activity mitigates resistance to neoadjuvant chemotherapy in locally advanced rectal cancer.
Journal: Proceedings of the National Academy of Sciences of the United States of America
Published: January 30, 2024
EZH2 mediated metabolic rewiring promotes tumor growth independently of histone methyltransferase activity in ovarian cancer.
Journal: Molecular cancer
Published: November 02, 2022
A Protocol for Digitalized Collection of Traditional Chinese Medicine (TCM) Pulse Information Using Bionic Pulse Diagnosis Equipment.
Journal: Phenomics (Cham, Switzerland)
Published: May 21, 2022
Construction and validation of a nomogram to predict overall survival in patients with breast sarcoma.
Journal: Frontiers in oncology
Published: April 07, 2022
Last Updated: 09/26/2026